Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?
- PMID: 17393135
- DOI: 10.1007/s00125-007-0640-1
Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?
Abstract
The relative effect of visceral and subcutaneous obesity on the risk of chronic metabolic disease has been a matter of long-term dispute. While ample data support either of the fat depots being causative or associative, valid argument for one depot often automatically belittles the other. Paradigms such as the visceral/portal hypothesis and the acquired lipodystrophy/ectopic fat storage and endocrine hypothesis have been proposed. Nevertheless, neither hypothesis alone explains the entire pathophysiological setting. Treatment of diabetes with thiazolidinediones selectively increases fat partitioning to the subcutaneous adipose depot but does not change visceral fat accumulation. This is in contrast to the preferential visceral fat mobilisation by diet and exercise. Surgical removal of visceral or subcutaneous adipose tissue yields relatively long-lasting metabolic improvement only when combined with procedures that ameliorate adipose tissue cell composition. These studies illustrate that human adipose tissue in different anatomic locations does not work in isolation, and that there is a best-fit relationship in terms of volume and function among different fat depots that needs to be met to maintain the systemic energy balance and to prevent the complications related to obesity.
Similar articles
-
The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.Int J Obes (Lond). 2006 Jun;30(6):877-83. doi: 10.1038/sj.ijo.0803212. Int J Obes (Lond). 2006. PMID: 16418758
-
The regulation of adipose tissue distribution in humans.Int J Obes Relat Metab Disord. 1996 Apr;20(4):291-302. Int J Obes Relat Metab Disord. 1996. PMID: 8680455 Review.
-
Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study.Am J Med. 2018 Jun;131(6):684-692.e12. doi: 10.1016/j.amjmed.2018.02.002. Epub 2018 Mar 5. Am J Med. 2018. PMID: 29518370 Free PMC article.
-
[Visceral, subcutaneous or intramuscular fat: where is the problem?].Arq Bras Endocrinol Metabol. 2004 Dec;48(6):803-11. doi: 10.1590/s0004-27302004000600005. Epub 2005 Mar 8. Arq Bras Endocrinol Metabol. 2004. PMID: 15761553 Review. Portuguese.
-
Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity.Obesity (Silver Spring). 2007 May;15(5):1155-63. doi: 10.1038/oby.2007.618. Obesity (Silver Spring). 2007. PMID: 17495191
Cited by
-
Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease.Diabetes Care. 2013 Sep;36(9):2822-9. doi: 10.2337/dc12-2617. Epub 2013 May 13. Diabetes Care. 2013. PMID: 23670996 Free PMC article. Clinical Trial.
-
Anthropometric Obesity Indices were Stronger than CT-Based Indices in Associations with Carotid Intima-Media Thickness in Japanese Men.J Atheroscler Thromb. 2019 Dec 1;26(12):1102-1114. doi: 10.5551/jat.47977. Epub 2019 May 15. J Atheroscler Thromb. 2019. PMID: 31092764 Free PMC article.
-
COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice.Oncotarget. 2017 Oct 23;8(55):94805-94818. doi: 10.18632/oncotarget.21998. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212268 Free PMC article.
-
Emerging Perspectives on the Impact of Diabetes Mellitus and Anti-Diabetic Drugs on Premenstrual Syndrome. A Narrative Review.Diabetes Ther. 2024 Jun;15(6):1279-1299. doi: 10.1007/s13300-024-01585-8. Epub 2024 Apr 26. Diabetes Ther. 2024. PMID: 38668996 Free PMC article. Review.
-
Accuracy of Y-scope, a newly developed portable abdominal impedance analyzer, for the assessment of abdominal visceral fat area.Front Nutr. 2022 Oct 12;9:950747. doi: 10.3389/fnut.2022.950747. eCollection 2022. Front Nutr. 2022. PMID: 36313090 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous